SLC44A2 and COVID-19: GWAS have suggested a role for SLC44A2 in regulating thrombosis, which involves mitochondria in platelets (74); this is of particular interest as formation of microthrombosis in cerebral vessels is considered a major cause of brain pathology in COVID-19.